Winst gevend schreef op 24 oktober 2024 11:35:
Alles groen, maar aandeel rood bij Pharming.
- Total revenues increased by 25% to US$ 204.5 million.
- Operating profit increased to US$ 4.1 million.
- Overall cash and marketable securities increased to US$ 173.3 million.
Closed US $ 1 million short from break-even
Planning for a new CEO
Opex costs dropped from 70.1 (Q2) to 64.7 M (Q3)
Cash increased from US $ 161.8 M (Q2) to US $ 173.3 M (Q3)
Beloning -10% om 11:30 uur
Over waanzin gesproken. :-)